Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
365
-
Total 13F shares, excl. options
-
16,780,107
-
Shares change
-
-2,306,590
-
Total reported value, excl. options
-
$5,090,432,479
-
Value change
-
-$691,524,112
-
Put/Call ratio
-
186%
-
Number of buys
-
159
-
Number of sells
-
-141
-
Price
-
$303.35
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q4 2014
442 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q4 2014.
ISHARES TR - ISHARES BIOTECH (IBB) has 365 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,780,107 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (2,077,846 shares), MORGAN STANLEY (1,780,880 shares), DEUTSCHE BANK AG\ (1,539,670 shares), BANK OF AMERICA CORP /DE/ (1,470,251 shares), UBS Group AG (1,189,907 shares), CITIGROUP INC (1,093,871 shares), JPMORGAN CHASE & CO (952,414 shares), CREDIT SUISSE AG/ (472,374 shares), CHURCHILL MANAGEMENT Corp (358,513 shares), and MANAGED ACCOUNT ADVISORS LLC (308,111 shares).
This table shows the top 365 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.